BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12031379)

  • 1. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
    Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
    Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
    Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
    Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen progression after radical prostatectomy in African-American men versus white men.
    Banerjee M; Powell IJ; George J; Biswas D; Bianco F; Severson RK
    Cancer; 2002 May; 94(10):2577-83. PubMed ID: 12173323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should African-American men be tested for prostate carcinoma at an earlier age than white men?
    Powell IJ; Banerjee M; Sakr W; Grignon D; Wood DP; Novallo M; Pontes E
    Cancer; 1999 Jan; 85(2):472-7. PubMed ID: 10023717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of location and multifocality of positive surgical margins on disease-free survival following radical prostatectomy: a comparison between African-American and white men.
    Shekarriz B; Tiguert R; Upadhyay J; Gheiler E; Powell IJ; Pontes JE; Grignon DJ; Sakr W; Wood DP
    Urology; 2000 Jun; 55(6):899-903. PubMed ID: 10840105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.
    Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM
    Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
    Howard LE; Zhang J; Fishbane N; Hoedt AM; Klaassen Z; Spratt DE; Vidal AC; Lin D; Hitchins MP; You S; Freeman MR; Yamoah K; Davicioni E; Freedland SJ
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):419-428. PubMed ID: 31844180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.
    Epstein M; Syed K; Danella J; Ginzburg S; Belkoff L; Tomaszewski J; Trabulsi E; Singer EA; Jacobs BL; Raman JD; Guzzo TJ; Uzzo R; Reese AC
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):257-263. PubMed ID: 37821578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, tumor location, and disease progression among low-risk prostate cancer patients.
    Mygatt JG; Cullen J; Streicher SA; Kuo HC; Chen Y; Young D; Gesztes W; Williams G; Conti G; Porter C; Stroup SP; Rice KR; Rosner IL; Burke A; Sesterhenn I
    Cancer Med; 2020 Mar; 9(6):2235-2242. PubMed ID: 31965751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
    Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
    Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
    J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
    Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
    Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
    Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
    J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.